In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the frontline of an emerging field of medicine, taking readers inside the clinic and offering a doctor’s perspective on what it really means [...]
A new survey of more than 3,500 medical cannabis patients in Germany has found that more than half were able to reduce their use of other prescription medications. Data published by Bloomwell Group in its latest ‘Cannabis Barometer’ report indicates that more than half (58.9%) of [...]
The Welsh Liberal Democrats have passed a motion designed to safeguard medical cannabis patients and protect them from discrimination. The party voted overwhelmingly to approve the motion at its spring conference in Cardiff in March, marking what some have described as a critical step forward for [...]
Cannabis Europa, the leading B2B conference for the European cannabis industry, has announced the full programme for its 2026 London edition. Taking place at The Barbican on 26 and 27 May, the event will bring together more than 70 speakers — regulators, investors, clinicians and operators [...]
Researchers found that people who consumed THC were more likely to recall words that were never shown to them and had more trouble completing everyday memory tasks, such as remembering to do something later. Published in the Journal of Psychopharmacology, the results from the double-blind placebo-controlled [...]
The Irish government has appointed a public health academic to chair a formal review of its now five-year-old Medical Cannabis Access Programme (MCAP) following months of parliamentary pressure. Despite launching in 2021, a recent (March 18, 2026) written ministerial answer reveals that less than 100 patients have been approved [...]
A small pilot study has found preliminary evidence to suggest that the FDA-approved CBD formulation, Epidiolex, may have benefits for weight restoration and symptom improvement in anorexia patients. Anorexia Nervosa (AN) is a severe mental illness, marked by an intense fear of gaining weight and persistent [...]
On the second anniversary of Germany’s landmark Cannabis Act (CanG) coming into force, the most comprehensive data and analysis of its impact to date has been published. Last week, the government published the results of the second Ekocan (Evaluation des Konsumcannabisgesetzes) evaluation, providing vital new details [...]
Words by Ben Stevens & Sarah Sinclair A new campaign is calling for urgent regulatory changes to how medical cannabis is prescribed to psychiatric patients in the UK, following what is believed to be the first time a coroner has found that a prescription for cannabis [...]
New research suggests that long-term, heavy cannabis use is associated with subtle changes to the frontal cortex, the part of the brain involved in decision-making and executive function. The study, the findings of which were presented at the 2026 European Congress of Psychiatry this month, focused [...]
By Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine, taking [...]
A major new systematic review has concluded that the available evidence rarely justifies the routine prescribing of cannabinoids for mental health conditions and substance use disorders. This study has been covered by a significant portion of the largest mainstream media outlets both in the UK and internationally, and [...]
New research suggests that two non-psychoactive cannabis compounds could help treat fatty liver disease, the most common form of chronic liver disorder. Researchers at the Hebrew University of Jerusalem have found that Cannabidiol (CBD) and Cannabigerol (CBG), can significantly reduce liver fat and improve metabolic health [...]
In a fascinating deep dive into human physiology, Dr. Rowan Thompson, resident doctor and Vice Chair of the Medical Cannabis Clinicians Society (MCCS), explores the Endocannabinoid System (ECS)—a complex biological network that remains largely untaught in medical schools despite its pivotal role in maintaining internal balance, [...]
A new UK-wide service supporting medical cannabis patients who face discrimination has launched to fill gaps left by the absence of systematic government support. Patient Protect was founded by patient advocate Alex Fraser and cannabis lawyer Robert Jappie, who have handled cases on a pro-bono basis for several years. The [...]
Labour MP and long-time medical cannabis advocate, Tonia Antoniazzi, has called on the government to fund a new observational trial to support children with drug-resistant epilepsy, who are still unable to access medical cannabis on the NHS. Antoniazzi is spearheading a new campaign launched in memory [...]
Ananda Pharma has cleared the final regulatory hurdle needed to begin its ENDOCAN Phase 2 clinical trial, receiving approval from the MHRA and NHS Health Research Authority to commence dosing of its proprietary MRX1 CBD oral solution in women with endometriosis-associated pain. The milestone marks a [...]
As cannabis research continues to progress, increasing attention is being given to two promising compounds, cannabigerol (CBG) and its precursor, cannabigerolic acid (CBG-A). Often overshadowed by the more widely recognised cannabinoids THC and CBD, these non-psychoactive compounds are now being explored for their therapeutic potential. Broughton, [...]
In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine, taking readers inside the clinic and offering a doctor’s perspective on what it really [...]
Polish pharmacies dispensed nearly 5,450 kilograms of dried cannabis flower in 2025, a 12% increase from the prior year, according to new data obtained by Prohibition Partners. By October, monthly volumes had surpassed the pre-ban peak for the first time, reaching a new all-time high in December. [...]
A UK medical cannabis patient has won a Crown Court appeal after being wrongly convicted of driving with THC above the legal limit. At Winchester Crown Court on 10 February 2026, Sal Aziz, a legally prescribed medical cannabis patient, was fully acquitted of the charges after [...]
Bristol Medical School has formally approved what is believed to be one of the first student-selected medical cannabis teaching placements offered by a UK university. The move marks a significant step forward for undergraduate education in an area of practice that remains widely under-taught. Despite medical [...]
Early findings examining the impact of the partial legalisation of cannabis in Germany suggest no short-term spike in consumption or related driving offences, alongside a sharp drop in prosecutions. Researchers at the University Medical Center Hamburg-Eppendorf (UKE) in Germany have investigated the short-term effects of the [...]
The first administrative appeal hearing on whether Female Orgasmic Disorder (FOD) should be recognised as a qualifying condition for medical cannabis is taking place in the US state of Oregon this week. From 3 to 5 February, state officials will hear testimony from clinicians, researchers, and [...]
A new study suggests a combination approach may provide the benefits of THC treatment in Alzheimer’s with fewer negative side effects. Researchers from The University of Texas at San Antonio paired a low-dose THC extract with the selective anti-inflammatory drug celecoxib. Their findings, published in Aging and [...]
A comprehensive guide on how to read and interpret cannabis research. Why Reading Research Matters The volume of cannabis research has never been higher, but not all studies are created equal. Every week brings new claims about cannabinoids relieving pain, aiding sleep, or reducing anxiety, yet [...]
A recent peer-reviewed paper has identified a previously unrecognised form of reporting bias that may be skewing how medical cannabis evidence is presented. The paper, published in Research Integrity and Peer Review, introduces the concept of reverse spin bias – a pattern in which authors of systematic [...]
In the first double-blind, placebo-controlled trial, vaporised cannabis was found to be more effective for treating acute migraine symptoms than a placebo. While preclinical and retrospective studies have suggested cannabinoids may be effective in migraine treatment, according to the researchers, until now, there have been no [...]
Researchers in the UK have proposed new thresholds for monitoring cannabis use – modelled on alcohol units – which they say could help people avoid potentially harmful consumption. The threshold recommendations, proposed in a paper published in the journal Addiction, are based on a system for [...]
Patients and healthcare professionals have responded to recent media coverage, which they say misrepresented those receiving treatment with cannabis-based medicines in the UK. On 6 January 2026, the National Police Chiefs’ Council (NPCC) approved the first official guidance on medical cannabis for officers in England and [...]
A new initiative is giving patients a direct voice in how the UK’s medical cannabis market is shaped, as global producers look to better understand the needs of the community. Launching this month, Patient Panel is a new medical cannabis market research consultancy that aims to [...]
Last week, the first official guidance on medical cannabis for police officers in England and Wales was made public. Its publication marks a significant step forward for both the patient community and law enforcement, finally providing an initial standardised set of principles for both to adhere [...]
Over seven years after medical cannabis was legalised in the UK, the National Police Chiefs’ Council has approved the first official guidance for medical cannabis. The guidance, titled ‘Medicinal Cannabis and the Police – Guidance for Officers and Staff’, crucially calls for officers in England and [...]
In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine, taking readers inside the clinic and offering a doctor’s perspective on what it really [...]
From tighter telemedicine rules to evolving product frameworks, as global medical cannabis markets mature, many are entering a more cautious phase as we head into 2026. After a broadly optimistic and reform-driven 2024, this year saw momentum begin to shift once again for the global medical [...]
Dr Simon Erridge, Head of Research, Curaleaf Clinic, reflects on some of the key findings published from the UK Medical Cannabis Patient Registry this year. As we look back on 2025, it’s been another year of deepening understanding about how medical cannabis is being used in [...]
A team of scientists testing the effects of CBD and THC on ovarian cancer cells have found that both show promising anti-cancer effects. While still in the early stages, researchers say these preliminary findings from the laboratory present an important opportunity to develop effective new therapies [...]
Chancellor Rachel Reeve’s recent budget announcement is yet to be fully digested, and the implications for UK businesses and the wider public are still being analysed. However, one thing remains clear: growth is the priority. As we heard repeatedly at this week’s Cannabis Health Symposium, the [...]
As a new review highlights significant gaps in the evidence base for medical cannabis, researchers have called for more rigorous studies and access to “balanced information” to support healthcare professionals and their patients. The authors of a new comprehensive review have concluded that medical cannabis lacks [...]
UK cannabinoid-based medicines manufacturer, 113 Botanicals, is raising £2 million to help launch its first controlled-release capsule, designed to improve dosing consistency and expand options for patients and prescribers. Working in partnership with scientists at the University of Sussex since 2020, the company is developing new [...]
Adults with chronic pain who participated in New York State’s (NYS) Medical Cannabis Program were significantly less likely to require prescription opioids, according to a new study. The study, published in JAMA Internal Medicine and led by researchers at Albert Einstein College of Medicine and Montefiore [...]
A new paper adds to growing calls for urgent improvements in police training on how to respond to patients prescribed cannabis-based medicines. The research explores how regulations introduced in 2018, making it legal for specialists to prescribe medical cannabis, have not been ‘consistently implemented’, or ‘adequately [...]
The Medical Cannabis Clinicians Society (MCCS) has released a landmark guide setting out standardised dosing protocols for cannabis oils, in what the organisation describes as a major step forward for safe, consistent prescribing across the UK. The publication, which officially launched at the Cannabis Health Symposium [...]
The afternoon sessions at Tuesday’s inaugural Cannabis Health Symposium 2025 moved beyond the fundamentals of cannabis medicine and its potential, to the practical realities of prescribing this relatively new medicine in the UK. These in-depth talks spanned everything from pharmacy standards and product quality to the specific challenges [...]
On Tuesday, November 25, nearly 200 healthcare professionals, patient advocates, cannabis educators, and industry leaders converged on London’s Conway Hall for the inaugural Cannabis Health Symposium. The event embodied the UK medical cannabis industry’s collective drive to push beyond its own barriers and reach out to the wider medical community [...]
In her bi-weekly series for Cannabis Health, Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine, taking readers inside the clinic and offering a doctor’s perspective on what it really [...]
Medical Cannabis Awareness Week has expanded for 2025, with an entire month of momentum-building events and educational initiatives, as organisations in the sector mark seven years since the law change. Over the last few years, Medical Cannabis Awareness Week has become an important date in the [...]
Seven years after medical cannabis was legalised in the UK, new data from Releaf sheds light on how the treatment is changing patients’ lives, but also where progress is still needed. This month, Releaf Cannabis Clinic published one of the most comprehensive surveys of UK medical [...]
Medical cannabis patients made history with a patient-led educational event about cannabis-based medicines, held at the Charterhouse in London. The international patient-led organisation We, The Patients, brought its educational event series to London for the first time on Friday 7 November, in partnership with PatientsCann UK, [...]
Curaleaf Laboratories, one of the UK’s leading providers of medicinal cannabis products, is pleased to announce a landmark partnership with Australian Natural Therapeutics Group (ANTG), one of Australia’s most respected producers of pharmaceutical-grade medicinal cannabis. Under this agreement, Curaleaf Laboratories will manufacture and distribute ANTG’s range of [...]
Copyright © 2020 – 2025 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
